Massachusetts General Hospital. “Safety and Effectiveness of Omega-3 Fatty Acids, EPA Versus DHA, for the Treatment of Major Depression.” ClinicalTrials.gov website, U.S. National Institutes of Health. 2006–2009. Available online at http://www.clinicaltrials.gov/ct2/show/NCT00361374?term=major+depression+Omega&rank=1.
Menninger, K. The Vital Balance. New York: Viking, 1963.
Menninger, W. “Psychiatric Experience in the War, 1941–1946.” American Journal of Psychiatry 103, no. 5 (March 1947): 577–86.
Meyer, A. The Commonsense Psychiatry of Dr. Adolf Meyer, edited by Alfred Lief. New York: McGraw Hill, 1948.
———. “The ‘Complaint’ as the Center of Genetic-Dynamic and Nosological Teaching in Psychiatry.” New England Journal of Medicine 199, no. 8 (1928): 360–70.
———. “A Few Demonstrations of the Pathology of the Brain.” American Journal of Insanity 52 (1895): 238–45.
———. “Presidential Address: Twenty-Five Years of Psychiatry in the United States and Our Present Outlook.” American Journal of Psychiatry 8 (July 1928): 1–31.
Mintz, M. “‘Heroine’ of FDA Keeps Bad Drug off Market.” Washington Post, July 15, 1962: p. A1.
Monfils, Paul. “Murex Shells Used to Produce Dye.” Man and Mollusc website, edited by Avril Bourquin. Available online at http://www.manandmollusc.net/Shell_photos/dye-murex.html.
“Morgan’s Old Gold.” Time, May 28, 1928. Available online at http://www.time.com/time/magazine/article/0,9171,786005,00.html.
Multidisciplinary Association for Psychedelic Studies website. Available online at www.maps.org.
Narrow, W. E., D. S. Rae, L. N. Robins, and D. A. Regier. “Revised Prevalence Estimates of Mental Disorders in the United States: Using a Clinical Significance Criterion to Reconcile 2 Surveys’ Estimates.” Archives of General Psychiatry 59, no. 2 (2002): 115–30.
National Institute of Mental Health. “Drug Therapy to Treat Minor Depression.” Clinicaltrials.gov website, U.S. National Institutes of Health, 2002–2009. Available online at http://www.clinicaltrials.gov/ct2/show/NCT00048815?term=minor+depression&rank=1.
National Institutes of Health. www.ClinicalTrials.gov.
Neslin, Scott. “Executive Summary: ROI Analysis of Pharmaceutical Promotion.” RxPromoROI website. Available online at www.rxpromoroi.org/rapp/exec_sum.html.
———. “RAPP Study.” RxPromorROI website, 2002. Available online at http://www.rxpromoroi.org/rapp/index.html.
New York Times. “American Loses Suit against Freud.” May 25, 1927.
———. “City Agents Hunt Supplies of Drug.” April 12, 1958, p. 1.
———. “Death of Woman Laid to ‘Pep Pills.’” April 11, 1958.
———. “Dr. Sakel Is Dead; Psychiatrist, 57.” Dec. 3, 1957.
———. “Physician Warns on Wonder Drugs.” April 13, 1960.
———. “Warns of Danger in American Life.” June 5, 1927.
Nuland, S. Doctors: The Biography of Medicine. New York: Knopf, 1988.
Nurnberg, H. G., P. L. Hensley, J. R. Heiman, H. A. Croft, C. DeBattista, and S. Paine. “Sildenafil Treatment of Women with Antidepressant-Associated Sexual Dysfunction: A Randomized Controlled Trial.” JAMA 300, no. 4 (2008): 395–404.
Office of National Drug Control Policy. “National Drug Control Strategy, FY 2009 Budget Summary.” Executive Summary. Available online at http://www.whitehousedrugpolicy.gov/publications/policy/09budget/exec_summ.pdf.
Olfsun, M., and S. Marcus. “National Patterns in Antidepressant Medication Treatment.” Archives of General Psychiatry 66, No. 8 (2009): 848–56.
Parens, E. “Kramer’s Anxiety.” In Prozac as a Way of Life, edited by C. Elliott and T. Chambers, 21–32. Chapel Hill, NC: University of North Carolina Press, 2004.
Parker, G., and K. Fletcher. “Treating Depression with the Evidence-Based Psychotherapies: A Critique of the Evidence.” Acta Psychiatrica Scandinavica 115 (2007): 352–59.
Peale, Norman Vincent. The Power of Positive Thinking. New York: Fawcett Columbine, 1966.
Pearce, J. M. S. “Leopold Auenbrugger: Camphor-Induced Epilepsy—Remedy for Manic Psychosis.” European Neurology 59 (2008): 105–7.
Pfizer. “Myths and Facts about Depression.” Zoloft (Sertraline HCI) website, 2008. Available online at http://www.zoloft.com/depr_myths_facts.aspx.
“Pharmacy Facts and Figures.” Drug Topics website. Available online at http://drugtopics.modernmedicine.com/drugtopics/article/articleList.jsp?categoryId=7604.
Pliny. [Gaius Plinius Secundus], Natural History: A Selection. London: Penguin Classics, 1991.
Popper, K. The Poverty of Historicism. New York: Harper & Row, 1957.
Popper, K. R., and J. C. Eccles. The Mind and Its Brain: An Argument for Interactionism. London: Routledge & Kegan Paul, 1977.
Preston, S. D., and F. B. de Waal. “Empathy: Its Ultimate and Proximate Bases.” The Behavioral and Brain Sciences 25 (2002): 1–20.
“Prontosil.” Time, December 28, 1936.
Quetel, C. History of Syphilis, translated by J. Braddock and B. Pike. Baltimore, MD: Johns Hopkins University Press, 1992.
Reader’s Digest. “Depression Hurts: Prozac Can Help.” Advertisement. May 1998, pp. 182–84.
Regier, D. A. “State-of-the-Art Psychiatric Diagnosis.” World Psychiatry 3, no. 1 (2004): 25–26.
“Relieves Anxiety and Anxious Depression.” Miltown advertisement. Archives of General Psychiatry 8, no. 2 (1963), following p. 135.
Richardson, R. D. William James: In the Maelstrom of American Modernism. Boston: Houghton Mifflin, 2006.
Richeson, J. S., A. A. Baird, H. L. Gordon, T. F. Heatherton, C. L. Wyland, S. Trawalter, and J. N. Shelton. “An fMRI Investigation of the Impact of Interracial Contact on Executive Function.” Nature Neuroscience 6, no. 12 (2003): 1323–28.
Rinkel, M., H. J. DeShon, and H. C. Solomon. “Experimental Schizophrenia-like Symptoms.” American Journal of Psychiatry 108 (1952): 572–78.
Rinkel, M., R. W. Hyde, H. C. Solomon, and H. Hoagland. “Experimental Psychiatry II: Clinical and Physio-chemical Observations in Experimental Psychoses.” American Journal of Psychiatry 111, no. 12 (1955): 881–95.
Robinson, L. A., J. S. Berman, and R. A. Neimeyer. “Psychotherapy for the Treatment of Depression: A Comprehensive Review of Controlled Outcome Research.” Psychological Bulletin 108 (1990): 30–49.
Roccatagliata, G. A History of Ancient Psychiatry. Santa Barbara, CA: Greenwood Press, 1986.
Rosenhan, D. “On Being Sane in Insane Places.” Science 179, no. 70 (Jan. 1973): 250–58.
Rosenzweig, S. “Some Implicit Common Factors in Diverse Methods of Psychotherapy.” American Journal of Ortho-psychiatry 6 (1936): 412–15.
Rush, A. J., A. T. Beck, M. Koracs, and S. Hollon. “Comparative Efficacy of Cognitive Therapy and Pharmacotherapy in the Treatment of Depressed Outpatients.” Cognitive Therapy and Research 1, no. 1 (1977): 17–37.
Rusk, H. A. “Drugs and Depression.” New York Times, September 6, 1959.
RxPromoROI: A Resource for Pharmaceutical Promotion ROI Results website. Available at www.rxpromoroi.org.
Sakel, M. “The Methodical Use of Hypoglycemia in the Treatment of Psychoses.” American Journal of Psychiatry 94 (1937): 111–29.
———. Schizophrenia. New York: Philosophical Library, 1958.
Sandifer, M. G., A. Hordern, G. C. Timbury, and L. M. Green. “Psychiatric Diagnosis: A Comparative Study in North Carolina, London, and Glasgow.” British Journal of Psychiatry 114 (1968): 1–9.
Schildkraut, J. “The Catecholamine Hypothesis of Affective Disorders.” American Journal of Psychiatry 122 (1965): 509–22.
Schmidt, J. Melancholy and the Care of the Soul: Religion, Moral Philosophy and Madness in Early Modern England. London: Ashgate Publishing, 2007.
Schmiege, G. R. “The Current State of LSD as a Therapeutic Tool: A Summary of the Clinical Literature.” Journal of the Medical Society of New Jersey 60 (1963): 203–7.
Seligman, M. “The Effectiveness of Psychotherapy: The Consumer Reports Study.” American Psychologist 50 (1996): 965–74.
———. “Learned Helplessness in the Rat.” Journal of Comparative and Physiological Psychology 88 (1975): 534–41.
Shapiro, A. K., and E. Shapiro. The Powerful Placebo: From Ancient Priest to Modern Physician. Baltimore, MD: Johns Hopkins University Press, 1997.
Shapiro, D. A. “Meta-analysis of Comparative Therapy Outcome Studies: A Replication and Refinement.” Psychological Bulletin 92 (1982): 581–604.
Shapiro, D. A., M. Barkham, A. Rees, G. E. Hardy, S. Reynolds, and M. Startup. “Effects of Treatment Duration and Severity of Depression on the Effectiveness of Cognitive-Behavioral Therapy and Psychodynamic-Interpersonal Psychotherapy.” Journal of Consulting and Clinical Psychology 62, no. 3 (1994): 522–34.
Sherman, I. W. Twelve Diseases That Changed Our World. Washington, DC: AMS Press, 2007.
Shorter, E. Before Prozac: The Troubled History of Mood Disorders in Psychiatry. Oxford: Oxford University Press, 2008.
———. “A History of Psychiatry: From the Era of the Asylum to the Age of Prozac.” New York: John Wiley & Sons, 1997.
Shorter, E., and D. Healy. Shock Therapy: A History of Electroconvulsive Treatment in Mental Illness. New Brunswick, NJ: Rutgers University Press, 2007.
Simpson, D. “Phrenology and the Neurosciences: Contributions of FJ Gall and JG Spurzheim.” ANZ Journal of Surgery 75 (2005): 475–82.
Smith, G. P. “Pavlov and Integrative Physiology.” American Journal of Physiology—Regulatory, Integrative, and Comparative Physiology 279 (2000): R743–55.
Smith, M. L., and G. V. Glass. “Meta-analysis of Psychotherapy Outcome Studies.” American Psychologist 32 (1977): 752–60.
Smith, M. L., G. V. Glass, and T. I. Miller. The Benefits of Psychotherapy. Baltimore: Johns Hopkins University, 1980.
Solomon, D. A., A. C. Leon, T. I. Mueller, W. Coryell, J. J. Teres, M. A. Posternak, L. L. Judd, J. Endicott, and M. B. Keller. Tachyphylaxis in Unipolar Major Depressive Disorder. Journal of Clinical Psychiatry 66, no. 3 (March 2005): 283–90.
Spiegel, A. “The Dictionary of Disorder: How One Man Revolutionized Psychiatry.” The New Yorker, January 3, 2005. Available online at http://www.newyorker.com/archive/2005/01/03/050103fa_fact.
———. “More and More, Favored Psychotherapy Lets Bygones Be Bygones.” New York Times, Feb. 14, 2006.
Spielmans, G. I., S. A. Thielges, A. L. Dent, and R. P. Greenberg. “The Accuracy of Psychiatric Medication Advertisements in Medical Journals.” Journal of Nervous and Mental Disease 196, no. 4 (2008): 267–73.
Spitzer, R. L. “On Pseudoscience in Science, Logic in Remission, and Psychiatric Diagnosis: A Critique of Rosenhan’s ‘On Being Sane in Insane Places’” and accompanying commentary. Journal of Abnormal Psychology 84 (1975): 433–74.
Spitzer, R. L., and P. T. Wilson. “Nosology and the Official Psychiatric Nomenclature.” In Comprehensive Textbook of Psychiatry, edited by A. Freedman, H. Kaplan, and B. Sadock, 826–45. Baltimore: Williams & Wilkins, 1975.
Spitzer, R. L., J. Endicott, and E. Robins. “The Development of Diagnostic Criteria in Psychiatry.” Current Contents 19 (January 1989).
Stanfel, R. “Prozac Print Campaign.” In Encyclopedia of Major Marketing Campaigns, vol. 2, 506–7. Florence, KY: Gale Thompson, 2007.
Steinach, I. “Etiology of General Paresis.” Medical Record 54 (1898): 877–78.
Stevens, Jay. Storming Heaven: LSD and the American Dream. London: Heinemann, 1987.
Stevenson, Robert Louis. “Requiem.” Poetry-Archive.com website. Available online at http://www.poetry-archive.com/s/requiem.html. Accessed March 29, 2009.
Szasz, T. The Myth of Mental Illness. New York: Harper & Row, 1961.
Tansey, E. M., and D. A. Christie. “Drugs in Psychiatric Practice.” In Transcript of a Witness Seminar Held at the Wellcome Institute for the History of Medicine, London, on 11 March 1997. London: Wellcome Institute, 1997.
Taylor, M. A., and M. Fink. “Restoring Melancholia in the Classification of Mood Disorders.” Journal of Affective Disorders 105 (2008): 1–14.
Temin, P. Taking Your Medicine: Drug Regulation in the United States. Cambridge, MA: Harvard University Press, 1980.
Thomas, L. The Medusa and the Snail: More Reflections of a Biology Watcher. New York: Viking, 1970.
Thuillier, J. Ten Years That Changed the Face of Mental Illness. London: Martin Dunitz, 1999 (originally published 1981).
Tilburt, J. C., E. J. Emanuel, T. J. Kaptchuk, F. A. Curlin, and F. G. Miller. “Prescribing ‘Placebo Treatments’: Results of National Survey of US Internists and Rheumatologists.” British Medical Journal 337 (2008). Available online at http://www.bmj.com/cgi/content/full/337/oct23_2/a1938.
Tocqueville, Alexis de. Democracy in America, vol. 2. New York: Modern Library, 1990.
Travis, A. S. “Perkin’s Mauve: Ancestor of the Organic Chemical Industry.” Technology and Culture 31, no. 1 (1990): 51–82.
Turner, E. H., A. M. Matthews, E. Linardatos, R. A. Tell, and R. Rosenthal. “Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy.” New England Journal of Medicine 358, no. 3 (2008): 252–60.
Twarog, B. M. “Responses of a Molluscan Smooth Muscle to Acetylcholine and 5-hydroxytryptamine.” Journal of Cellular and Comparative Physiology 44, no. 1 (1954): 141–63.
Twarog, B. M., and I. H. Page. “Serotonin Content of Some Mammalian Tissues and Urine and a Method for its Determination.” American Journal of Physiology 175, no. 1 (1953): 157–61.
Ullmann, A. “Pasteur-Koch: Distinctive Ways of Thinking about Infectious Diseases.” Microbe 2, no. 8 (2007): 383–87.
Valenstein, E. S. The War of the Soups and the Sparks: The Discovery of Neurotransmitters and the Dispute over How Nerves Communicate. New York: Columbia University Press, 2005.
Van Wyhe, J. “The Authority of Human Nature: The Schädellehre of Franz Joseph Gall.” British Journal of the History of Science 35 (2002).
von Meduna, L. “The Significance of the Convulsive Reaction during the Insulin and the Cardiazol Therapy of Schizophrenia.” Journal of Nervous and Mental Disease 87, no. 2 (Feb. 1938): 133–40.
Waldinger, M. D. “Premature Ejaculation: Definition and Drug Treatment.” Drugs 67, no. 4 (2007): 547–68.
Wallace, B. A. The Taboo of Subjectivity: Toward a New Science of Consciousness. Oxford: Oxford University Press, 2000.
Wallace, D. F. “The Depressed Person.” In Brief Interviews with Hideous Men, 37–69. New York: Little, Brown, 2000.
Wampold, B. E. “Establishing Specificity in Psychotherapy Scientifically: Design and Evidence Issues.” Clinical Psychology Science and Practice 12 (2005): 197.
———. The Great Psychotherapy Debate: Models, Methods, and Findings. Mahwah, NJ: Erlbaum, 2001.
———. “Methodological Problems in Identifying Efficacious Psychotherapies.” Psychotherapy Research 7, no. 1 (1997): 21–43.
Wampold, B. E., G. W. Mondin, M. Moody, F. Stich, K. Benson, and H. Ahn. “A Meta-analysis of Outcome Studies Comparing Bona Fide Psychotherapies: Empirically, ‘All Must Have Prizes.’” Psychological Bulletin 122, no. 3 (1997): 203–15.
Manufacturing depression Page 47
